Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ryan Nelson

Executive Editor

Washington, D.C.
Ryan Nelson is managing editor of Informa’s Rose Sheet and the head of its cosmetics content channel, with particular expertise in evolving regulatory and legal issues. He’s been covering FDA-regulated industries for going on 15 years, previously reporting for the Gray Sheet (now Medtech Insight) where he handled beats including Capitol Hill and Emerging Technology. He began his career teaching English Literature to 9th grade boys at a private boarding school in Chattanooga, Tennessee, a role he misses only occasionally. Ryan is based in Informa’s Washington, D.C. office.
Set Alert for Articles By Ryan Nelson

Latest From Ryan Nelson

Overwhelmed J&J Talc Supplier Takes Cover Under Bankruptcy Protections

“It is simply not in the best interests of our stakeholders to litigate these claims in perpetuity,” says Imerys Talc America President Giorgio La Motta of the company’s decision to reorganize its business and debts under Chapter 11 in negotiation with claimants in cosmetic talc-related suits.

Legal Issues Business Strategies

FDA Warns Korean Firm Soleo For GMP Violations, Unapproved Shampoo Drug

Soleo’s Marum GENtLE THERAPY Shampoo, marketed as an anti-dandruff and hair-growth treatment, is an unapproved new drug, according to FDA. The agency’s warning letter, citing “significant” CGMP violations, follows an August 2018 inspection of the firm’s Pyeongtaek-based facility.

Beauty Health

FTC: Paying A Big-Name Beauty Influencer To Smear A Competitor Is Unlawful … In These Contexts

Marketing insiders are denouncing the growing trend of beauty companies weaponing influencers against competing brands. Mary Engle, associate director of FTC’s Division of Advertising Practices, discusses the practice and lines that shouldn’t be crossed, blurry as they may well be.

Beauty Advertising, Marketing & Sales

Never Mind Next-Gen UV Filters; Existing Sunscreen Ingredients’ GRASE Status May Be In Danger

FDA aims to publish a tentative final monograph for OTC sunscreen drugs in 2019 that identifies “data gaps that FDA believes need to be filled” for 16 currently listed UV filters to support their continued marketing in the US without new drug approvals.

Regulation FDA

ECHA Targets Cosmetics, Leave-On And Rinse-Off Alike, With Proposed Microplastics Ban

Manufacturers of rinse-off and leave-on cosmetics would have four years and six years, respectively, to comply with ECHA’s proposed restriction on intentionally added microplastics, efforts that ECHA estimates would cost industry around $1.1bn and $7.4bn over 20 years. Microbeads in rinse-off exfoliating/cleansing cosmetics, largely phased out already, would be banned without delay.

Beauty Regulation

Is Clinique’s ‘Fresh Pressed’ A Natural Claim? UK’s Ad Authority Issues Ruling

Fushi Wellbeing – which markets a range of organic, fresh-pressed face oils derived from the cherry seed, baobab seed and argan nut, among other natural sources – challenged Clinique’s Fresh Pressed line name in light of the brand’s heavy reliance on chemically derived ingredients.

Beauty Ad Complaints
See All